J J Wendler1, M Pech2, J Köllermann3, B Friebe2, S Siedentopf4, S Blaschke5, D Schindele5, M Porsch6, D Baumunk7, J Jürgens2, F Fischbach2, J Ricke8, M Schostak5, M Böhm9, U B Liehr5. 1. Department of Urology, Otto von Guericke University of Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. johann.wendler@med.ovgu.de. 2. Department of Radiology, Otto von Guericke University of Magdeburg, Magdeburg, Germany. 3. Department of Pathology, Sana Medical Center Offenbach, Offenbach, Germany. 4. Department of Pathology, Otto von Guericke University of Magdeburg, Magdeburg, Germany. 5. Department of Urology, Otto von Guericke University of Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. 6. Urological Practice, Magdeburg, Germany. 7. Urological Practice, Stuttgart, Germany. 8. Department of Radiology, Ludwig Maximilians University of Munich, Munich, Germany. 9. Urological Practice, Dill-Clinics, Dillenburg, Germany.
Abstract
PURPOSE: Irreversible electroporation (IRE) is a new potential ablation modality for small renal masses. Animal experiments have shown preservation of the urine-collecting system (UCS). The purpose of this clinical study was to perform the first evaluation and comparison of IRE's effects on the renal UCS by using urinary cytology, magnetic-resonance imaging, and resection histology in men after IRE of pT1a renal-cell carcinoma (RCC). METHODS: Seven patients with biopsy-proven RCC pT1a cN0cM0 underwent IRE in a phase 2a pilot ablate-and-resect study (IRENE trial). A contrast-enhanced, diffusion-weighted MRI and urinary cytology was performed 1 day before and 2, 7, and 27 days after IRE. Twenty-eight days after IRE the tumour region was completely resected surgically. RESULTS: Technical feasibility was demonstrated in all patients. In all cases, MRI revealed complete coverage of the tumour area by the ablation zone with degenerative change. The urographic late venous MRI phase (urogram scans) demonstrated normal morphological appearances. Urine cytology showed a temporary vacuolisation of the cyto- and caryoplasmas after IRE. Whereas the urothelium showed signs of regeneration 28 days after IRE-ablation, the tumour and parenchyma below it showed necrosis and permanent tissue destruction. CONCLUSIONS: Renal percutaneous IRE appears to be a safe treatment for pT1a RCC. The preservation of the UCS with unaltered normal morphology as well as urothelial regeneration and a phenomenon (new in urinary cytology) of temporary degeneration with vacuolisation of detached transitional epithelium cells were demonstrated in this clinical pilot study.
PURPOSE: Irreversible electroporation (IRE) is a new potential ablation modality for small renal masses. Animal experiments have shown preservation of the urine-collecting system (UCS). The purpose of this clinical study was to perform the first evaluation and comparison of IRE's effects on the renal UCS by using urinary cytology, magnetic-resonance imaging, and resection histology in men after IRE of pT1a renal-cell carcinoma (RCC). METHODS: Seven patients with biopsy-proven RCC pT1a cN0cM0 underwent IRE in a phase 2a pilot ablate-and-resect study (IRENE trial). A contrast-enhanced, diffusion-weighted MRI and urinary cytology was performed 1 day before and 2, 7, and 27 days after IRE. Twenty-eight days after IRE the tumour region was completely resected surgically. RESULTS: Technical feasibility was demonstrated in all patients. In all cases, MRI revealed complete coverage of the tumour area by the ablation zone with degenerative change. The urographic late venous MRI phase (urogram scans) demonstrated normal morphological appearances. Urine cytology showed a temporary vacuolisation of the cyto- and caryoplasmas after IRE. Whereas the urothelium showed signs of regeneration 28 days after IRE-ablation, the tumour and parenchyma below it showed necrosis and permanent tissue destruction. CONCLUSIONS: Renal percutaneous IRE appears to be a safe treatment for pT1a RCC. The preservation of the UCS with unaltered normal morphology as well as urothelial regeneration and a phenomenon (new in urinary cytology) of temporary degeneration with vacuolisation of detached transitional epithelium cells were demonstrated in this clinical pilot study.
Authors: Mara Buijs; Daniel M de Bruin; Peter Gk Wagstaff; Patricia J Zondervan; Matthijs JV Scheltema; Marc W Engelbrecht; Maria P Laguna; Krijn P van Lienden Journal: Diagn Interv Radiol Date: 2021-09 Impact factor: 2.630